Commentary highlights methodological concerns in predicting measles immunization coverage for 2026 in Mexico, indicating need for clearer analysis.
I write to comment and clarify a few points on the paper predicting MCV1 immunization coverage in Mexico for 2026 [1]. This public health emergency in Mexico and other countries deserves close attention and analysis, for which I congratulate the authors of this study, but believe there is a need for clarification for this paper to appropriately inform policy.
No takes yet. Share an insight, caveat, or question.
Hector E. Velasco-Mondragon (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: